Table A3.
Information on Number of Patients Who Switched Their Assignment, and ED Visits at the First and Last Month of Follow Up.
| Drug Group | # of Patients | # of Months of Follow Up | # of Events | # of Patients Switched (%) | Average # of ED Visits at the First Month of Follow Up | Average # of ED Visits at the Last Month of Follow Up |
|---|---|---|---|---|---|---|
| Aripiprazole | 982 | 9.76 | 38 | 115 (12) | 0.47 | 0.29 |
| Haloperidol | 822 | 4.38 | 28 | 65 (8) | 1.18 | 0.63 |
| Lurasidone | 209 | 7.94 | 0 | 30 (14) | 0.44 | 0.42 |
| Olanzapine | 510 | 7.05 | 22 | 79 (15) | 0.68 | 0.47 |
| Perphenazine | 427 | 5.2 | 3 | 14 (3) | 0.57 | 0.42 |
| Quetiapine | 1429 | 9.04 | 38 | 166 (12) | 0.55 | 0.43 |
| Risperidone | 693 | 9 | 17 | 127 (18) | 0.54 | 0.37 |
| Ziprasidone | 222 | 8.02 | 11 | 23 (10) | 0.49 | 0.39 |
ED visits: emergency department visits; #: Number.